Epilepsy Fundamentals Refresher Series - Part 3
In the third part of this series, Dr. Halley Alexander explores emerging trends and recent advances in epilepsy. Show citation: Tolchin B, Goldstein LH, Reuber M, et al. Management of Functional Sei...
7 Heinä 2min
Epilepsy Fundamentals Refresher Series - Part 2
In part two of this series, Dr. Halley Alexander discusses seizure types, epilepsy types, and the etiology of epilepsy. Show citations: Beniczky S, Trinka E, Wirrell E, et al. Updated classification...
6 Heinä 3min
Communication About Uncertainty During PD Diagnostic Consultations
Dr. Greg Cooper and Dr. Elisabeth Kurpershoek discuss how clinicians communicate uncertainty during Parkinson's disease diagnosis and how this impacts patient trust and understanding. Show citation: ...
3 Heinä 2min
Comparing Sensitivity of Nerve Biopsy, Skin Biopsy, and Fat Aspirate in ATTRv-PN
Dr. Katie Krulisky and Dr. Marcus Pinto discuss the diagnosis and management of hereditary ATTR amyloidosis. Show citation: Panrudkevich AH, Jones FJS, Shouman K, et al. Sensitivity of Nerve and Skin...
2 Heinä 2min
Epilepsy Fundamentals Refresher Series - Part 1
In part one of this series, Dr. Halley Alexander explores epilepsy diagnosis. Previously posted Neurology Minute episodes related to epilepsy syndromes and their diagnosis. Show citation: Fisher RS...
1 Heinä 3min
Low Prevalence and Inconsistency of LRP4-IgG Detection in Suspected MG
Dr. Aaron Zelikovich discusses the frequency of LRP4-IgG in patients with suspected MG using different cell-based assay protocols. Show citation: Vacchiano V, Milano DC, Ricciardiello F, et al. Low ...
30 Kesä 2min
2026 European Stroke Organization Conference - Part 2
In part two of this series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the use of dual antiplatelet therapy with intravenous thrombolysis in patients with acute ischaemic stroke. Read mo...
29 Kesä 3min
2026 European Stroke Organization Conference - Part 1
In part one of this series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss insights from the LATE-MT trial that was presented at the 2026 European Stroke Organization Conference. Read more a...
26 Kesä 3min
